NASDAQ · Biotechnology

Rocket One, Inc (HOTH) Stock

$1.13 -23.65% NASDAQ: HOTH Healthcare

Rocket One, Inc. engages in the development of new generation therapies for dermatological disorders.

Valuation

MetricValue
Price$1.13
Market Cap$14.92M
P/E Ratio-0.70
P/B Ratio1.40
P/S Ratio0.00
EPS (TTM)$-0.90
52-Week High$2.45
52-Week Low$0.49
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-200.00%
ROA-150.00%
ROCE-157.14%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio7.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-14.0M$-11.0M$-8.0M$-8.0M$-11.0M
Net Profit$-14.0M$-11.0M$-8.0M$-8.0M$-12.0M
EPS$-16.03$-9.50$-2.30$-1.28$-0.90
Op Margin

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$11.0M$7.0M$10.0M$8.0M$8.0M
Total Liabilities$1.0M$2.0M$1.0M$1.0M$1.0M
Cash$9.0M$6.0M$9.0M$7.0M$6.0M
Borrowings$0$0$0$0$0

Latest News

Dollar Eases as Focus Turns to Fed’s Meeting The Wall Street Journal · Jul 23, 2026 Acrab Unveils GΞLIX 1 SoC and Agent Box, Bringing State-of-the-Art AI to the Edge CNW Group · Jul 23, 2026 Primary Hydrogen Announces Marketing Services Agreement TMX Newsfile · Jul 23, 2026 Hyundai Profit Falls as Weak Auto Demand, Labor Unrest Weigh The Wall Street Journal · Jul 23, 2026 Is an AMD Stock Split Likely After Aug. 4? Motley Fool · Jul 23, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-12.0M$-9.0M$-8.0M$-7.0M$-10.0M
Investing Cash Flow$0$1.0M$0$0$0
Financing Cash Flow$0$0$0$4.0M$0
Net Cash Flow$6.0M$-2.0M$3.0M$-2.0M$-1.0M
Free Cash Flow$-12.0M$-9.0M$-8.0M$-7.0M$-10.0M

Valuation & Return Ratios

MetricValue
PEG Ratio
EV / EBITDA
FCF Yield-123.91%
Quick Ratio3.39
Interest Coverage
Return 1Y
Return 3Y
Return 5Y

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ASBP $7.26 +3.13% -0.74 $837601 0.00%
BCTX $3.53 +1.73% -0.04 $6.65M 0.00%
CRIS $4.69 -4.09% -0.35 $9.14M 0.00%
DARE $1.32 +3.13% -1.94 $12.57M 0.00%
ENTOEntero Therapeutics, Inc. $2.85 -5.00% -0.82 $13.58M 0.00%

About Rocket One, Inc

Rocket One, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in Hoboken, NJ.

Rocket One, Inc is led by CEO Robb Knie, employs 2 people, headquartered in US, publicly traded since 2019.

Rocket One, Inc (HOTH) stock trades at $1.13 with a market capitalization of $14.92M. The stock is valued at a price-to-earnings (P/E) ratio of -0.70, price-to-book of 1.40, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.49 and $2.45, and currently trades 53.9% below its 52-week high.

On profitability, Rocket One, Inc generates a return on equity (ROE) of -200.00%, return on capital employed of -157.14%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides